DBV Technologies (DBV) Price & Analysis

Compare

11 Followers

DBV Stock Chart & Stats

Day’s Range― - ―

52-Week Range€0.51 - €2.38

Previous CloseN/A

Volume1.76M

Average Volume (3M)523.25K

Market Cap

€232.38M

Enterprise Value€138.86M

Total Cash (Recent Filing)€103.21M

Total Debt (Recent Filing)€8.29M

Price to Earnings (P/E)―

Beta0.60

Next Earnings

Oct 29, 2025

EPS Estimate

-0.06

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.27

Shares Outstanding136,948,870

10 Day Avg. Volume665,505

30 Day Avg. Volume523,252

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)2.31

Price to Sales (P/S)15.24

P/FCF Ratio-0.59

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€3.65

Price Target Upside114.71% Upside

Rating ConsensusHold

Number of Analyst Covering2

DBV Technologies News

DBV Technologies appoints James Briggs as chief human resources officer

DBV Technologies (DBVT) announced the appointment of James Briggs as its chief human resources officer, succeeding Caroline Daniere....

17d ago

DBVT

Dbv Technologies Advances Peanut Allergy Treatment with New Study Update

Dbv Technologies SA (UK) (($GB:0QAJ)) announced an update on their ongoing clinical study. Dbv Technologies SA is conducting...

8d ago

0QAJ

DBV Technologies’ Viaskin Peanut Program: Strategic Advancements and Regulatory Pathways Pave the Way for Investment Opportunities

Analyst Andrew Fein from H.C. Wainwright maintained a Buy rating on DBV Technologies SA – American and keeping...

9d ago

DBVT

DBV Technologies: Advancing Viaskin Peanut Towards FDA Approval with Strong Financial Backing

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on DBV Technologies SA...

9d ago

DBVT

Dbv Technologies Advances Peanut Allergy Patch Study for Toddlers

Dbv Technologies SA (UK) (($GB:0QAJ)) announced an update on their ongoing clinical study. Dbv Technologies SA is conducting...

18d ago

0QAJ

Dbv Technologies’ Peanut Allergy Study: A Potential Game-Changer for Pediatric Treatment

Dbv Technologies SA (UK) (($GB:0QAJ)) announced an update on their ongoing clinical study. Dbv Technologies SA is conducting...

1M ago

0QAJ

Positive Outlook for DBV Technologies SA Driven by Promising Phase 3 Trial and Market Expansion Potential for Viaskin Peanut

Analyst Sam Slutsky from LifeSci Capital maintained a Buy rating on DBV Technologies SA – American (DBVT –...

1M ago

DBVT

DBV Technologies’ Peanut Allergy Patch Study: A Promising Step Forward

Dbv Technologies SA (UK) (($GB:0QAJ)) announced an update on their ongoing clinical study. Study Overview: The clinical study...

1M ago

0QAJ

DBV Technologies announces first subject screened in COMFORT Toddlers trial

DBV Technologies (DBVT) provided an update on the progress on the company’s COMFORT Toddlers supplemental safety study using...

1M ago

DBVT

Nvidia upgraded, Salesforce downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

2M ago

Cautious Outlook on DBV Technologies: Sell Rating Amid Commercialization and Market Risks

DBV Technologies (0QAJ) has received a new Sell rating, initiated by Goldman Sachs analyst, Rajan Sharma. Rajan Sharma...

2M ago

DBVT

DBV Technologies reinstated with a Sell at Goldman Sachs

Goldman Sachs analyst Rajan Sharma reinstated coverage of DBV Technologies (DBVT) with a Sell rating and $7.25 price...

2M ago

DBVT

DBV Technologies price target raised to $21 from $15 at Citizens JMP

Citizens JMP raised the firm’s price target on DBV Technologies (DBVT) to $21 from $15 and keeps an...

2M ago

DBVT

Buy Rating for DBV Technologies Driven by Promising Viaskin Peanut Potential and Strong Market Opportunity

Sam Slutsky, an analyst from LifeSci Capital, has initiated a new Buy rating on DBV Technologies SA –...

3M ago

DBVT

DBV FAQ

What was Dbv Technologies SA (UK)’s price range in the past 12 months?

Dbv Technologies SA (UK) lowest stock price was €0.51 and its highest was €2.38 in the past 12 months.

What is Dbv Technologies SA (UK)’s market cap?

Dbv Technologies SA (UK)’s market cap is €232.38M.

When is Dbv Technologies SA (UK)’s upcoming earnings report date?

Dbv Technologies SA (UK)’s upcoming earnings report date is Oct 29, 2025 which is in 82 days.

How were Dbv Technologies SA (UK)’s earnings last quarter?

Dbv Technologies SA (UK) released its earnings results on Jul 29, 2025. The company reported -€0.27 earnings per share for the quarter, missing the consensus estimate of -€0.031 by -€0.239.

Is Dbv Technologies SA (UK) overvalued?

According to Wall Street analysts Dbv Technologies SA (UK)’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Dbv Technologies SA (UK) pay dividends?

Dbv Technologies SA (UK) does not currently pay dividends.

What is Dbv Technologies SA (UK)’s EPS estimate?

Dbv Technologies SA (UK)’s EPS estimate is -0.06.

How many shares outstanding does Dbv Technologies SA (UK) have?

Dbv Technologies SA (UK) has 136,948,870 shares outstanding.

What happened to Dbv Technologies SA (UK)’s price movement after its last earnings report?

Dbv Technologies SA (UK) reported an EPS of -€0.27 in its last earnings report, missing expectations of -€0.031. Following the earnings report the stock price went down -1.684%.

Which hedge fund is a major shareholder of Dbv Technologies SA (UK)?

Currently, no hedge funds are holding shares in FR:DBV

Company Description

Dbv Technologies SA (UK)

DBV Technologies is a clinical-stage biopharmaceutical company, based in France, focused on developing innovative products for the diagnosis and treatment of food allergies. The company's proprietary technology, Viaskin, is a patented delivery platform that administers biologically active compounds to the immune system through intact skin without allowing them to pass into the bloodstream. DBV Technologies primarily targets the allergy sector with its lead product candidate, Viaskin Peanut, which is designed to treat peanut allergies in children.

DBV Technologies (DBV) Earnings & Revenues

Historic Earnings Reports

DBV Stock 12 Month Forecast

Average Price Target

€3.65

▲(114.71% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"€1","3":"€3","5":"€5","7":"€7","-1":"-€1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€3.65</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€1.30</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,1,3,5,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Sep<br/>2024","9":"Jan<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.562,1.9033846153846155,2.2447692307692306,2.586153846153846,2.9275384615384614,3.268923076923077,3.6103076923076918,3.9516923076923076,4.293076923076923,4.634461538461538,4.975846153846153,5.317230769230769,5.658615384615384,{"y":6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.562,1.7226153846153847,1.8832307692307693,2.043846153846154,2.2044615384615387,2.365076923076923,2.525692307692308,2.6863076923076923,2.846923076923077,3.007538461538462,3.1681538461538463,3.3287692307692307,3.4893846153846155,{"y":3.65,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.562,1.5418461538461539,1.5216923076923077,1.5015384615384615,1.4813846153846155,1.4612307692307693,1.4410769230769231,1.420923076923077,1.4007692307692308,1.3806153846153846,1.3604615384615384,1.3403076923076924,1.3201538461538462,{"y":1.3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.857,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.73,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.388,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.244,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.815,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.878,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.834,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.712,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.769,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.63,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.745,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.589,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.562,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >